Alimera Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Alimera Sciences generated cash of -$14,261,000, which is less than the previous year. Cash used in financing activities reached the amount of $96,499,000 last year. Net change in cash is therefore $6,786,000.
Cash Flow
| 2014 | -24.30M | -25.84M | 114.74M |
|---|---|---|---|
| 2015 | -45.36M | -451K | 625K |
| 2016 | -25.09M | -186K | 25.42M |
| 2017 | -12.87M | -238K | 5.72M |
| 2018 | -11.55M | -175K | 950K |
| 2019 | -4.15M | -174K | 869K |
| 2020 | -2.19M | -620K | 3.88M |
| 2021 | -3.22M | -621K | 9.82M |
| 2022 | -9.97M | -255K | -302K |
| 2023 | -14.26M | -75.53M | 96.49M |
ALIM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.30M | 16.54M | 11.24M | 9.45M | 13.07M | 24.10M | 30.97M | 31.07M | 76.69M | 12.62M |
Operating activities | ||||||||||
Net income | -20.13M | -18.10M | -4.37M | -5.33M | -10.44M | -16.38M | -22.00M | -33.17M | -30.64M | -35.91M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 8.74M | 2.70M | 2.57M | 2.67M | 2.64M | 2.64M | 2.68M | 2.76M | 2.55M | 659K |
Stock-based compensation expense | 1.43M | 910K | 997K | 1.33M | 2.45M | 0 | 4.98M | 4.88M | 5.03M | 3.85M |
| Deferred income tax benefit | 1.43M | 910K | 997K | 1.33M | 2.45M | 0 | 4.98M | 4.88M | 5.03M | 3.85M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -17.15M | -863K | -2.20M | 2.63M | -2.16M | -5.99M | 2.61M | -4.09M | -8.91M | -444K |
Inventories | -260K | 1.01M | -19K | -1.25M | 996K | -933K | -1.05M | 1M | -386K | -135K |
Accounts payable | -1.87M | 1.46M | 1.48M | 106K | 779K | 556K | 644K | 1.07M | -487K | 2.98M |
Cash generated by operating activities | -14.26M | -9.97M | -3.22M | -2.19M | -4.15M | -11.55M | -12.87M | -25.09M | -45.36M | -24.30M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -75.53M | -255K | -621K | -620K | -174K | -175K | -238K | -186K | -451K | -25.84M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -75.53M | -255K | -621K | -620K | -174K | -175K | -238K | -186K | -451K | -25.84M |
Financing activities | ||||||||||
Common Stock Issued | 2.40M | 85K | 10.08M | 49K | 902K | 83K | 6.08M | 0 | 1.00M | 37.59M |
Payments for dividends | -1.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -314K | 0 | 0 | 0 | 0 | -122K | 0 | 0 | 0 | 0 |
Repayments of term debt | 22.01M | -289K | -221K | -445K | -33K | -35.32M | -182K | -227K | -293K | -4.87M |
Cash used in financing activities | 96.49M | -302K | 9.82M | 3.88M | 869K | 950K | 5.72M | 25.42M | 625K | 114.74M |
Net Change In Cash | 6.78M | -11.24M | 5.30M | 1.78M | -3.61M | -11.02M | -6.91M | -96K | -45.62M | 64.06M |
Cash at end of period | 12.09M | 5.30M | 16.54M | 11.24M | 9.45M | 13.07M | 24.06M | 30.97M | 31.07M | 76.69M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |